699 related articles for article (PubMed ID: 28602879)
1. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
[TBL] [Abstract][Full Text] [Related]
2. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
Ethier JL; Desautels DN; Templeton AJ; Oza A; Amir E; Lheureux S
Gynecol Oncol; 2017 Jun; 145(3):584-594. PubMed ID: 28222899
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.
Zhan H; Ma JY; Jian QC
Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.
Gu XB; Tian T; Tian XJ; Zhang XJ
Sci Rep; 2015 Jul; 5():12493. PubMed ID: 26205001
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.
Li MX; Liu XM; Zhang XF; Zhang JF; Wang WL; Zhu Y; Dong J; Cheng JW; Liu ZW; Ma L; Lv Y
Int J Cancer; 2014 May; 134(10):2403-13. PubMed ID: 24122750
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Templeton AJ; McNamara MG; Šeruga B; Vera-Badillo FE; Aneja P; Ocaña A; Leibowitz-Amit R; Sonpavde G; Knox JJ; Tran B; Tannock IF; Amir E
J Natl Cancer Inst; 2014 Jun; 106(6):dju124. PubMed ID: 24875653
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis.
Jiang T; Qiao M; Zhao C; Li X; Gao G; Su C; Ren S; Zhou C
Cancer Immunol Immunother; 2018 May; 67(5):713-727. PubMed ID: 29423649
[TBL] [Abstract][Full Text] [Related]
11. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.
Gu X; Gao X; Li X; Qi X; Ma M; Qin S; Yu H; Sun S; Zhou D; Wang W
Sci Rep; 2016 Feb; 6():22089. PubMed ID: 26912340
[TBL] [Abstract][Full Text] [Related]
14. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review.
Wu J; Chen M; Liang C; Su W
Oncotarget; 2017 Feb; 8(8):13400-13412. PubMed ID: 28077792
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.
Bowen RC; Little NAB; Harmer JR; Ma J; Mirabelli LG; Roller KD; Breivik AM; Signor E; Miller AB; Khong HT
Oncotarget; 2017 May; 8(19):32171-32189. PubMed ID: 28418870
[TBL] [Abstract][Full Text] [Related]
18. Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis.
Jin J; Yang L; Liu D; Li W
BMJ Open; 2020 Jun; 10(6):e035031. PubMed ID: 32499266
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis.
Zou P; Yang E; Li Z
Sci Rep; 2020 Dec; 10(1):21917. PubMed ID: 33318608
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]